Putnam Investments’s Fulgent Genetics FLGT Stock Holding History

Putnam Investments’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$647K	Sell	22,363 -3,466	-13%	-$92.7K	﹤0.01%	903
2023 Q3	$691K	Sell	25,829 -222	-0.9%	-$7.58K	﹤0.01%	879
2023 Q2	$965K	Sell	26,051 -810	-3%	-$28.2K	﹤0.01%	850
2023 Q1	$839K	Sell	26,861 -7,432	-22%	-$239K	﹤0.01%	874
2022 Q4	$1.02M	Sell	34,293 -19	-0.1%	-$680	﹤0.01%	834
2022 Q3	$1.31M	Sell	34,312 -621	-2%	-$31.1K	﹤0.01%	811
2022 Q2	$1.91M	Sell	34,933 -431	-1%	-$23.7K	﹤0.01%	754
2022 Q1	$2.21M	Buy	35,364 +2,836	+9%	+$187K	﹤0.01%	785
2021 Q4	$3.27M	Buy	+32,528	New	+$2.86M	﹤0.01%	674
2017 Q2	–	Sell	-349,700	Closed	-$3.82M	–	1175
2017 Q1	$3.82M	Sell	349,700 -25,000	-7%	-$296K	0.01%	701
2016 Q4	$4.33M	Buy	374,700 +4,400	+1%	+$41.5K	0.01%	626
2016 Q3	$3.41M	Buy	+370,300	New	+$3.41M	0.01%	693

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Putnam Investments's FLGT Position: Q4 2023 in Review

Putnam Investments reduced its Fulgent Genetics (FLGT) stake by 13% in Q4 2023, selling an estimated $92.7K and leaving 22,363 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #903.

Putnam Investments first reported a position in FLGT in Q3 2016 and has held it in 12 quarters since. The position peaked at $4.33M in Q4 2016. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

Putnam Investments held 22,363 shares of Fulgent Genetics worth $647K as of Q4 2023.
Putnam Investments sold 3,466 Fulgent Genetics shares in Q4 2023, an estimated $92.7K.
Fulgent Genetics made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #903 holding.
Putnam Investments first reported a position in Fulgent Genetics in Q3 2016 and has held it in 12 quarters since.
Putnam Investments's Fulgent Genetics position peaked at $4.33M in Q4 2016.
196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.